Therapeutic Cannabinoid Focus

The Therapeutic Cannabinoid Focus family encompasses cultivars selectively bred to express elevated levels of non-intoxicating cannabinoids such as CBD, CBG, CBC, and CBN alongside variable THC profiles. These strains emerge from deliberate crossing programs and phenotype selection rather than a shared ancestral lineage, making them a functional classification rather than a traditional family tree. Breeders working in this category often cross high-cannabinoid parents with established genetics to stabilize desirable ratios. Lineage records frequently report crosses between European CBD-dominant cultivars, Swiss landrace derivatives, and cannabinoid-rich industrial hemp genetics. This category represents a relatively recent shift in breeding focus toward non-intoxicating compound expression.

Breeders in this focus use marker-assisted selection and cannabinoid profiling to identify and stabilize plants expressing specific ratios of CBD:THC, CBG expression, or minor cannabinoid prominence. These genetics serve as parent material for creating cultivars suited to various cultivation environments and regulatory frameworks where cannabinoid profiles take precedence over traditional terpene-